In this study, the efficacy of coenzyme Q10 and a conventional drug to treat heart failure was analysed in patients with an inflammation of the heart muscle (myocarditis). The patients were divided into three groups: the first group received only coenzyme Q10 (42 patients), the second group received only the conventional heart medication (39 patients), and the third group received a combination of coenzyme Q10 and the medication (43 patients). Both products individually decreased inflammation markers and oxidative stress. However, combination therapy showed a significantly improved effect. More details can be found in the study.


Shao et al.


Link to article >>